Nanogrow Biotech
PrivateLast Round
Seed
Nov 26, 2025
Total Funding Raised
$2.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nanogrow Biotech is a biotechnology company that develops biological therapies based on camelid-derived single-domain antibodies for the treatment of immune-mediated diseases and cancer in humans and animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanogrow Biotech Comparables
Compare Nanogrow Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abkyu, Inc. | 81% | |
| Cortalix B.V. | 80% | |
| Cerberus Therapeutics | 80% |
Nanogrow Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 26, 2025 | ||||
| Seed | Apr 29, 2024 | ||||
| Seed | Apr 1, 2024 |
Key People
Founding team and executive leadership
Nanogrow Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GRIDX | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 55% MoM.
- Jun 27, 2026
Grew 28% QoQ, from 18 to 23 employees.
Nanogrow Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanogrow Biotech's valuation, stock price, and market status.
Is Nanogrow Biotech a public or private company?
Nanogrow Biotech is a private company.
What is the current stock price of Nanogrow Biotech?
Nanogrow Biotech is a private company, so its shares have no public market price. Caplight tracks Nanogrow Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanogrow Biotech worth (valuation)?
Valuation information for Nanogrow Biotech is not publicly available.
Can I buy Nanogrow Biotech stock?
Nanogrow Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanogrow Biotech's last funding round?
Nanogrow Biotech's most recent funding round was Seed on November 26, 2025.
Who are the main investors in Nanogrow Biotech?
Key investors in Nanogrow Biotech include GRIDX.
Will Nanogrow Biotech IPO soon?
No public IPO plans have been announced for Nanogrow Biotech.
How can I track Nanogrow Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Nanogrow Biotech's shares on secondary markets.